Health research and knowledge translation for achieving the sustainable development goals: tackling the hurdles.

We are far from reaching the sustainable development goals (SDGs) for health despite a wealth of novel insights in disease mechanisms and possible solutions. Why have we failed in knowledge translation and implementation?

Starting from the case of cardiovascular diseases as one of the most prevalent non-communicable diseases, we examine barriers and hurdles, and perspectives for future health research. Health has multiple links with other SDGs. To accelerate the progress towards a healthy society, health research needs to take a broader view and become more cross-disciplinary and cross-sectoral.

As one example, behavioural studies will underpin better prevention and treatment adherence. The next generation workforce in health and research needs an adapted education and training to implement more effective health approaches.

4-Arm PEG-GA
abx085098-200l 200 µl
EUR 712.5

4-Arm PEG-GA
abx085098-20kDa5g 20 kDa; 5 g
EUR 760.8

4-Arm PEG-GA
abx085098-2kDa1g 2 kDa; 1 g
EUR 427.2

8-Arm PEG-GA
abx085109-100l 100 µl
EUR 250

8-Arm PEG-GA
abx085109-10kDa1g 10 kDa; 1 g
EUR 393.6

8-Arm PEG-GA
abx085109-10kDa5g 10 kDa; 5 g
EUR 744

8-Arm PEG-GA
abx085109-1ml 1 ml
EUR 275

8-Arm PEG-GA
abx085109-200l 200 µl
EUR 250

8-Arm PEG-GA
abx085109-20kDa5g 20 kDa; 5 g
EUR 744

8-Arm PEG-GA
abx085109-40kDa1g 40 kDa; 1 g
EUR 427.2

PEG-G-CSF
RP250004 Inquire Ask for price

4-Arm PEG-GAS
abx085093-100l 100 µl
EUR 312.5

4-Arm PEG-GAS
abx085093-10kDa1g 10 kDa; 1 g
EUR 526.8

4-Arm PEG-GAS
abx085093-10kDa5g 10 kDa; 5 g
EUR 878.4

4-Arm PEG-GAS
abx085093-1ml 1 ml
EUR 350

4-Arm PEG-GAS
abx085093-200l 200 µl
EUR 312.5

4-Arm PEG-GAS
abx085093-20kDa5g 20 kDa; 5 g
EUR 878.4

4-Arm PEG-GAS
abx085093-2kDa1g 2 kDa; 1 g
EUR 477.6

4-Arm PEG-GAA
abx085100-100l 100 µl
EUR 275

4-Arm PEG-GAA
abx085100-10kDa1g 10 kDa; 1 g
EUR 460.8

4-Arm PEG-GAA
abx085100-10kDa5g 10 kDa; 5 g
EUR 760.8

4-Arm PEG-GAA
abx085100-1ml 1 ml
EUR 300

4-Arm PEG-GAA
abx085100-200l 200 µl
EUR 275

4-Arm PEG-GAA
abx085100-20kDa5g 20 kDa; 5 g
EUR 760.8

4-Arm PEG-GAA
abx085100-2kDa1g 2 kDa; 1 g
EUR 427.2

8-Arm PEG-GAA
abx085111-100l 100 µl
EUR 250

8-Arm PEG-GAA
abx085111-10kDa1g 10 kDa; 1 g
EUR 393.6

8-Arm PEG-GAA
abx085111-10kDa5g 10 kDa; 5 g
EUR 744

8-Arm PEG-GAA
abx085111-1ml 1 ml
EUR 275

8-Arm PEG-GAA
abx085111-200l 200 µl
EUR 250

8-Arm PEG-GAA
abx085111-20kDa5g 20 kDa; 5 g
EUR 744

8-Arm PEG-GAA
abx085111-40kDa1g 40 kDa; 1 g
EUR 427.2

8-Arm PEG-GAS
abx085116-100l 100 µl
EUR 275

8-Arm PEG-GAS
abx085116-10kDa1g 10 kDa; 1 g
EUR 393.6

8-Arm PEG-GAS
abx085116-10kDa5g 10 kDa; 5 g
EUR 744

8-Arm PEG-GAS
abx085116-1ml 1 ml Ask for price

8-Arm PEG-GAS
abx085116-200l 200 µl
EUR 837.5

8-Arm PEG-GAS
abx085116-20kDa5g 20 kDa; 5 g
EUR 744

8-Arm PEG-GAS
abx085116-40kDa1g 40 kDa; 1 g
EUR 427.2

rHu PEG-GCSF (cGMP)
AK9032-0000 1mg Ask for price

PCL(5K)-PEG-Galactose
abx085406-100l 100 µl
EUR 762.5

PCL(5K)-PEG-Galactose
abx085406-1ml 1 ml Ask for price

PCL(5K)-PEG-Galactose
abx085406-200l 200 µl Ask for price

PCL(5K)-PEG-Galactose
abx085406-2kDa1g 2 kDa; 1 g
EUR 684

PCL(5K)-PEG-Galactose, 2K
HE116072-2K-G G
EUR 430.8
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

KRIBIOLISA PEG-GCSF (Pegylated Filgrastim) ELISA
KBBA10 1 x 96 wells
EUR 676.5

PEG2-(CH2CO2H)2
572081 1.0g
EUR 260

PEG3-(CH2CO2H)2
572082 500.0mg
EUR 610

PEG5-(CH2CO2H)2
572083 250.0mg
EUR 530

PEG6-(CH2CO2H)2
572084 250.0mg
EUR 530

PEG6-(CH2CO2H)2
HY-122702 100mg
EUR 97.4
Description: PEG6-(CH2CO2H)2 is a symmetric PEG PROTAC linker, for the synthesis of Homo-PROTACs which is bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation[1].

PEG6-(CH2CO2H)2
MBS3842886-100mg 100mg
EUR 230

PEG6-(CH2CO2H)2
MBS3842886-50mg 50mg
EUR 180

PEG6-(CH2CO2H)2
MBS3842886-5x100mg 5x100mg
EUR 1030

PEG6-(CH2CO2H)2
MBS5759043-100mg 100mg
EUR 200

PEG6-(CH2CO2H)2
MBS5759043-50mg 50mg
EUR 170

PEG6-(CH2CO2H)2
MBS5759043-5x100mg 5x100mg
EUR 750

PEG6-(CH2CO2H)2
T8232-10mg 10mg Ask for price
Description: PEG6-(CH2CO2H)2

PEG6-(CH2CO2H)2
T8232-1g 1g Ask for price
Description: PEG6-(CH2CO2H)2

PEG6-(CH2CO2H)2
T8232-1mg 1mg Ask for price
Description: PEG6-(CH2CO2H)2

PEG6-(CH2CO2H)2
T8232-50mg 50mg Ask for price
Description: PEG6-(CH2CO2H)2

PEG6-(CH2CO2H)2
T8232-5mg 5mg Ask for price
Description: PEG6-(CH2CO2H)2

AzoDye-2 PEG10 Alkyne
2435 1 mg
EUR 155
Description: AzoDye-2 PEG10 alkyne is an excellent building block for labeling azide-containing molecules.

AzoDye-2 PEG10 Alkyne
2435-1mg 1 mg
EUR 151
Description: AzoDye-2 PEG10 alkyne is an excellent building block for labeling azide-containing molecules.

4-Methylumbelliferyl 2-Acetamido-2-deoxy-alpha-D-galactopyranoside PEG2000 Ether
M333510 250mg
EUR 19000

4-Methylumbelliferyl 2-Acetamido-2-deoxy-alpha-D-galactopyranoside PEG2000 Ether
TRC-M333510-250MG 250 mg Ask for price

DBCO PEG13 NHS 2 µmol scale
26-6746-03 1 Each Ask for price

(2-pyridyldithio)-PEG4 acid
HY-135964 100 mg
EUR 432.91
Description: (2-pyridyldithio)-PEG4 acid is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1].

(2-Pyridyldithio)-PEG6 acid
HY-132086 Get quote Ask for price
Description: 2-Pyridyldithio-PEG6 acid is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1].

(2-pyridyldithio)-PEG4 acid
T17331-10mg 10mg Ask for price
Description: (2-pyridyldithio)-PEG4 acid

(2-pyridyldithio)-PEG4 acid
T17331-1g 1g Ask for price
Description: (2-pyridyldithio)-PEG4 acid

(2-pyridyldithio)-PEG4 acid
T17331-1mg 1mg Ask for price
Description: (2-pyridyldithio)-PEG4 acid

(2-pyridyldithio)-PEG4 acid
T17331-50mg 50mg Ask for price
Description: (2-pyridyldithio)-PEG4 acid

(2-pyridyldithio)-PEG4 acid
T17331-5mg 5mg Ask for price
Description: (2-pyridyldithio)-PEG4 acid

(2-Pyridyldithio)-PEG2-Boc
HY-141361 100 mg
EUR 108.23
Description: (2-Pyridyldithio)-PEG2-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].

(2-Pyridyldithio)-PEG2-Boc
T14018-10mg 10mg Ask for price
Description: (2-Pyridyldithio)-PEG2-Boc

(2-Pyridyldithio)-PEG2-Boc
T14018-1g 1g Ask for price
Description: (2-Pyridyldithio)-PEG2-Boc

(2-Pyridyldithio)-PEG2-Boc
T14018-1mg 1mg Ask for price
Description: (2-Pyridyldithio)-PEG2-Boc

(2-Pyridyldithio)-PEG2-Boc
T14018-50mg 50mg Ask for price
Description: (2-Pyridyldithio)-PEG2-Boc

(2-Pyridyldithio)-PEG2-Boc
T14018-5mg 5mg Ask for price
Description: (2-Pyridyldithio)-PEG2-Boc

JBScreen Classic 2 (PEG 4000 based)
M-CS-102L 24 solutions
EUR 249
Description: JBScreen Classic 2 (PEG 4000 based)

(2-Pyridyldithio)-PEG4-alcohol
HY-141359 100 mg
EUR 194.81
Description: (2-Pyridyldithio)-PEG4-alcohol is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].

(2-Pyridyldithio)-PEG4-alcohol
T14019-10mg 10mg Ask for price
Description: (2-Pyridyldithio)-PEG4-alcohol

(2-Pyridyldithio)-PEG4-alcohol
T14019-1g 1g Ask for price
Description: (2-Pyridyldithio)-PEG4-alcohol

(2-Pyridyldithio)-PEG4-alcohol
T14019-1mg 1mg Ask for price
Description: (2-Pyridyldithio)-PEG4-alcohol

(2-Pyridyldithio)-PEG4-alcohol
T14019-50mg 50mg Ask for price
Description: (2-Pyridyldithio)-PEG4-alcohol

(2-Pyridyldithio)-PEG4-alcohol
T14019-5mg 5mg Ask for price
Description: (2-Pyridyldithio)-PEG4-alcohol

(2-pyridyldithio)-PEG1-hydrazine
HY-136135 100 mg
EUR 54.11
Description: (2-pyridyldithio)-PEG1-hydrazine is a cleavable 1 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1].

(2-Pyridyldithio)-PEG4-propargyl
HY-141360 100 mg
EUR 216.45
Description: (2-Pyridyldithio)-PEG4-propargyl is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. (2-Pyridyldithio)-PEG4-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

(2-pyridyldithio)-PEG1-hydrazine
MBS5799142-INQUIRE INQUIRE Ask for price

(2-Pyridyldithio)-PEG4-propargyl
T14020-10mg 10mg Ask for price
Description: (2-Pyridyldithio)-PEG4-propargyl

(2-Pyridyldithio)-PEG4-propargyl
T14020-1g 1g Ask for price
Description: (2-Pyridyldithio)-PEG4-propargyl

(2-Pyridyldithio)-PEG4-propargyl
T14020-1mg 1mg Ask for price
Description: (2-Pyridyldithio)-PEG4-propargyl

(2-Pyridyldithio)-PEG4-propargyl
T14020-50mg 50mg Ask for price
Description: (2-Pyridyldithio)-PEG4-propargyl

(2-Pyridyldithio)-PEG4-propargyl
T14020-5mg 5mg Ask for price
Description: (2-Pyridyldithio)-PEG4-propargyl

(2-pyridyldithio)-PEG1-hydrazine
T38503-10mg 10mg Ask for price
Description: (2-pyridyldithio)-PEG1-hydrazine

(2-pyridyldithio)-PEG1-hydrazine
T38503-1g 1g Ask for price
Description: (2-pyridyldithio)-PEG1-hydrazine

(2-pyridyldithio)-PEG1-hydrazine
T38503-1mg 1mg Ask for price
Description: (2-pyridyldithio)-PEG1-hydrazine

(2-pyridyldithio)-PEG1-hydrazine
T38503-50mg 50mg Ask for price
Description: (2-pyridyldithio)-PEG1-hydrazine

(2-pyridyldithio)-PEG1-hydrazine
T38503-5mg 5mg Ask for price
Description: (2-pyridyldithio)-PEG1-hydrazine

pEGFP- MD2- 2
PVT10181 2 ug
EUR 361.2

pEGFP-C1-2
PVT14810 2 ug
EUR 444

pEGFP-C1-2
PVT27334 2ug
EUR 280

DBCO PEG4 NHS 2 µmol scale
26-6745-03 1 Each Ask for price

JBScreen Membrane 2 (PEG 2000 MME to PEG 10000 based)
M-CS-302L 24 solutions
EUR 414
Description: JBScreen Membrane 2 (PEG 2000 MME to PEG 10000 based)

PEG-2 Hydrogenated Tallow Amine
P159960 1g
EUR 673
Description: 61791-26-2

PEG-2 Hydrogenated Tallow Amine
TRC-P159960-250MG 250 mg Ask for price

PEG-2 Hydrogenated Tallow Amine
TRC-P159960-1G 1 g Ask for price

PEG-2 Hydrogenated Tallow Amine
TRC-P159960-5G 5 g Ask for price

Azide PEG4 NHS 2 µmol scale
26-6754-03 1 Each Ask for price

As well, only effective dialogue and communication between researchers, practitioners, society and policymakers can lead to translation of evidence into policies, addressing the complexity of socioeconomic factors and commercial interests. Within Europe, health research needs a comprehensive vision and strategy that connects to achieving better health, as one of the interconnected SDGs.